NDC 55513-488

LUMAKRAS

Sotorasib

LUMAKRAS is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Sotorasib.

Product ID55513-488_3b378de2-ac6e-4f2b-9d8a-9ea72f0f9374
NDC55513-488
Product TypeHuman Prescription Drug
Proprietary NameLUMAKRAS
Generic NameSotorasib
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2021-05-28
Marketing CategoryNDA /
Application NumberNDA214665
Labeler NameAmgen Inc
Substance NameSOTORASIB
Active Ingredient Strength120 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 55513-488-02

2 BOTTLE, PLASTIC in 1 CARTON (55513-488-02) > 120 TABLET, COATED in 1 BOTTLE, PLASTIC (55513-488-01)
Marketing Start Date2021-05-28
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [LUMAKRAS]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LUMAKRAS
LUMAKRAS
97248835 not registered Live/Pending
Amgen Inc.
2022-02-01
LUMAKRAS
LUMAKRAS
90532537 not registered Live/Pending
Amgen Inc,
2021-02-17
LUMAKRAS
LUMAKRAS
90044720 not registered Live/Pending
Amgen Inc.
2020-07-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.